| Citation: |
SHAN Xiaoli, CHI Runze, YU Xin, LI Bingong. Correlation between left atrial diameter and renal function in patients with atrial fibrillation[J]. Journal of Clinical Medicine in Practice, 2024, 28(9): 34-39. DOI: 10.7619/jcmp.20240497
|
To explore the correlation between left atrial diameter (LAD) and renal function in patients with atrial fibrillation.
A total of 364 patients with atrial fibrillation were selected as study subjects. Clinical data of the patients were collected, including gender, age, height, body weight, smoking history, drinking history, atrial fibrillation type, history of hypertension, coronary heart disease, diabetes, heart failure, medication history, high-sensitivity troponin I, brain natriuretic peptide, C-reactive protein, creatinine, urea nitrogen, LAD, left ventricular ejection fraction (LVEF), left ventricular end-diastolic diameter (LVDd), left ventricular posterior wall thickness (LVPWTd), and interventricular septal thickness (IVSTd). Estimated glomerular filtration rate (eGFR) and body mass index were calculated. Spearman correlation analysis was used to explore the correlations of LAD with creatinine, urea nitrogen, and eGFR. With eGFR < 60 mL/(min·1.73 m2) setting as renal insufficiency, univariate Logistic regression analysis was used to explore the influencing factors of renal insufficiency in patients with atrial fibrillation. Binary Logistic regression analysis was used to explore the relationship between LAD and renal insufficiency in patients with atrial fibrillation.
Spearman correlation analysis showed that LAD was positively correlated with creatinine (r=0.279, P < 0.001) and urea nitrogen (r=0.190, P < 0.001) in patients with atrial fibrillation, and negatively correlated with eGFR (r=-0.263, P < 0.001). Univariate Logistic regression analysis showed that gender, history of diabetes, hypertension, coronary heart disease, heart failure, atrial fibrillation type, sodium-glucose cotransporter 2 inhibitor medication history, diuretic medication history, LAD, LVEF, LVDd, and IVSTd were all influencing factors of renal insufficiency in patients with atrial fibrillation (P < 0.05). Binary Logistic regression analysis showed that compared with the first quartile of LAD (LAD ≤ 38 mm), the risk of renal insufficiency in patients with atrial fibrillation in the fourth quartile of LAD (LAD>47 mm) increased by 5.199 times(OR=5.199; 95 %CI, 1.210 to 22.337; P=0.027).
LAD of patients with atrial fibrillation is significantly related to renal function, and LAD is an influencing factor of renal insufficiency in patients with atrial fibrillation.
| [1] |
BAMAN J R, PASSMAN R S. Atrial fibrillation[J]. JAMA, 2021, 325(21): 2218. doi: 10.1001/jama.2020.23700
|
| [2] |
LIPPI G, SANCHIS-GOMAR F, CERVELLIN G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge[J]. Int J Stroke, 2021, 16(2): 217-221. doi: 10.1177/1747493019897870
|
| [3] |
WIJESURENDRA R S, CASADEI B. Mechanisms of atrial fibrillation[J]. Heart, 2019, 105(24): 1860-1867. doi: 10.1136/heartjnl-2018-314267
|
| [4] |
中华医学会心电生理和起搏分会, 中国医师协会心律学专业委员会, 中国房颤中心联盟心房颤动防治专家工作委员会. 心房颤动: 目前的认识和治疗建议(2021)[J]. 中华心律失常学杂志, 2022, 26(1): 15-88.
|
| [5] |
KASHANI K, ROSNER M H, OSTERMANN M. Creatinine: from physiology to clinical application[J]. Eur J Intern Med, 2020, 72: 9-14. doi: 10.1016/j.ejim.2019.10.025
|
| [6] |
WANG Y N, YANG Y, HE F. Insights into concomitant atrial fibrillation and chronic kidney disease[J]. Rev Cardiovasc Med, 2022, 23(3): 105. doi: 10.31083/j.rcm2303105
|
| [7] |
PATEL R B, FONAROW G C, GREENE S J, et al. Kidney function and outcomes in patients hospitalized with heart failure[J]. J Am Coll Cardiol, 2021, 78(4): 330-343. doi: 10.1016/j.jacc.2021.05.002
|
| [8] |
BARASHI R, HORNIK-LURIE T, GABAY H, et al. Renal function and outcome of patients with non-valvular atrial fibrillation[J]. Eur Heart J Acute Cardiovasc Care, 2021, 10(10): 1180-1186. doi: 10.1093/ehjacc/zuab075
|
| [9] |
米琴, 郭雪娅. 心房颤动与慢性肾脏病相关性研究[J]. 中华老年心脑血管病杂志, 2019, 21(2): 204-206. doi: 10.3969/j.issn.1009-0126.2019.02.025
|
| [10] |
RIMMELE D L, BOROF K, JENSEN M, et al. Association between carotid atherosclerosis and atrial fibrillation, cardiac, and renal function[J]. Eur J Vasc Endovasc Surg, 2022, 63(4): 641-647. doi: 10.1016/j.ejvs.2022.01.010
|
| [11] |
HU Y F, CHEN Y J, LIN Y J, et al. Inflammation and the pathogenesis of atrial fibrillation[J]. Nat Rev Cardiol, 2015, 12(4): 230-243. doi: 10.1038/nrcardio.2015.2
|
| [12] |
TAPOI L, URECHE C, SASCAU R, et al. Atrial fibrillation and chronic kidney disease conundrum: an update[J]. J Nephrol, 2019, 32(6): 909-917. doi: 10.1007/s40620-019-00630-1
|
| [13] |
KOZBERG M G, PEROSA V, GUROL M E, et al. A practical approach to the management of cerebral amyloid angiopathy[J]. Int J Stroke, 2021, 16(4): 356-369. doi: 10.1177/1747493020974464
|
| [14] |
FLORIA M, TANASE D M. Atrial fibrillation type and renal dysfunction: new challenges in thromboembolic risk assessment[J]. Heart, 2019, 105(17): 1295-1297. doi: 10.1136/heartjnl-2019-315212
|
| [15] |
PARK S, LEE S, KIM Y, et al. Atrial fibrillation and kidney function: a bidirectional Mendelian randomization study[J]. Eur Heart J, 2021, 42(29): 2816-2823. doi: 10.1093/eurheartj/ehab291
|
| [16] |
VAN DER BURGH A C, GEURTS S, IKRAM M A, et al. Bidirectional association between kidney function and atrial fibrillation: a population-based cohort study[J]. J Am Heart Assoc, 2022, 11(10): e025303. doi: 10.1161/JAHA.122.025303
|
| [17] |
GENG T T, WANG Y, LU Q, et al. Associations of new-onset atrial fibrillation with risks of cardiovascular disease, chronic kidney disease, and mortality among patients with type 2 diabetes[J]. Diabetes Care, 2022, 45(10): 2422-2429. doi: 10.2337/dc22-0717
|
| [18] |
张爱丽, 侯旗旗, 韩全乐, 等. 中国北方人群心房颤动与新发慢性肾脏病发病风险的相关性研究[J]. 中国全科医学, 2023, 26(36): 4521-4526. doi: 10.12114/j.issn.1007-9572.2023.0006
|
| [19] |
DING W Y, GUPTA D, WONG C F, et al. Pathophysiology of atrial fibrillation and chronic kidney disease[J]. Cardiovasc Res, 2021, 117(4): 1046-1059. doi: 10.1093/cvr/cvaa258
|
| [20] |
LÓPEZ-GALVEZ R, RIVERA-CARAVACA J M, ROLDÁN V, et al. Imaging in atrial fibrillation: a way to assess atrial fibrosis and remodeling to assist decision-making[J]. Am Heart J, 2023, 258: 1-16. doi: 10.1016/j.ahj.2022.12.007
|
| [21] |
THOMAS L, ABHAYARATNA W P. Left atrial reverse remodeling: mechanisms, evaluation, and clinical significance[J]. JACC Cardiovasc Imaging, 2017, 10(1): 65-77. doi: 10.1016/j.jcmg.2016.11.003
|
| [22] |
MILLS H, ESPERSEN K, JURLANDER R, et al. Prevention of sudden cardiac death in hypertrophic cardiomyopathy: risk assessment using left atrial diameter predicted from left atrial volume[J]. Clin Cardiol, 2020, 43(6): 581-586. doi: 10.1002/clc.23351
|
| [23] |
THOMAS L, MURARU D, POPESCU B A, et al. Evaluation of left atrial size and function: relevance for clinical practice[J]. J Am Soc Echocardiogr, 2020, 33(8): 934-952. doi: 10.1016/j.echo.2020.03.021
|
| [24] |
BEYER C, TOKARSKA L, STÜHLINGER M, et al. Structural cardiac remodeling in atrial fibrillation[J]. JACC Cardiovasc Imaging, 2021, 14(11): 2199-2208. doi: 10.1016/j.jcmg.2021.04.027
|
| [25] |
GOETTE A, LENDECKEL U. Atrial cardiomyopathy: pathophysiology and clinical consequences[J]. Cells, 2021, 10(10): 2605. doi: 10.3390/cells10102605
|
| [26] |
NGUYEN H T T, DO C V, DANG D T V, et al. Progressive alterations of left atrial and ventricular volume and strain across chronic kidney disease stages: a speckle tracking echocardiography study[J]. Front Cardiovasc Med, 2023, 10: 1197427. doi: 10.3389/fcvm.2023.1197427
|
| [27] |
CHEN S C, CHANG J M, TSAI Y C, et al. Left atrial diameter and albumin with renal outcomes in chronic kidney disease[J]. Int J Med Sci, 2013, 10(5): 575-584. doi: 10.7150/ijms.5845
|
| [28] |
HUANG T H, CHIU H, WU P Y, et al. The association of echocardiographic parameters on renal outcomes in chronic kidney disease[J]. Ren Fail, 2021, 43(1): 433-444. doi: 10.1080/0886022X.2021.1885444
|
| [29] |
HU L L, XIONG Q M, CHEN Z Q, et al. Factors associated with a large decline in renal function or progression to renal insufficiency in hospitalized atrial fibrillation patients with early-stage CKD[J]. Int Heart J, 2020, 61(2): 239-248. doi: 10.1536/ihj.19-205
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: